2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients

BACKGROUND: The diagnosis of C. difficile infection (CDI) relies on using a nucleic acid amplification test (NAAT) followed by confirmatory toxin enzyme immunoassay (EIA). This study examined the utility of fecal biomarkers and C. difficile bacterial quantity (BQ) in differentiating patients with tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Olvera, Adilene, Yepez Guevara, Eduardo, Garey, Kevin W, Dillon, Ryan J, Okhuysen, Pablo C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810411/
http://dx.doi.org/10.1093/ofid/ofz360.1913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810411/
http://dx.doi.org/10.1093/ofid/ofz360.1913

Ejemplares similares